This issue is the second section of a complete update to this publication which originally consisted of three separate editions - Vol. 1 (2003), Vols. 2 and 5 (2002) - and was reshaped into 2 editions – Vol. 1 and Vol. 2.

With a total of 83 companies surveyed (the Vol. 1 contains 71 companies), improvements were made to the report by adding a new study objective - their business strategies for the Chinese market, and by viewing movements of these companies from many other aspects including annual revenues, chemical compounds available, their unique technologies, R&D trends, and so forth. The “2005, Comprehensive Study of Pharmaceutical Intermediate / Bulk Producers, Vol. 2” provides you with an insight into the current outsourcing trends in pharmaceutical materials, in light of upcoming enforcement of the Pharmaceutical Affairs Law, as well as ever-increasing industrial focus on strategic international business development.